INCY logo Incyte : INCY

INCY

Stock Data

$120.56

Change up

$2.18 (1.84%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Incyte Corp is a biopharmaceutical company focused on developing and commercializing treatments for cancer and autoimmune diseases. It is known for its flagship product, JAKAFI, used in treating various blood-related disorders, and has a diverse portfolio including therapies for leukemia, lymphoma, and skin diseases. Incyte is actively involved in research, with several products in clinical trials aiming to address unmet medical needs in oncology and inflammation. The company collaborates with other pharmaceutical entities to expand its reach and improve patient care globally. Headquartered in Wilmington, Delaware, Incyte continues to innovate in the healthcare space.

Latest Activity

INCYIncyte Corp.
Reports Tue Jul 28Before open7:00 AM ETConfirmed

Incyte reports before the bell with Wall Street watching for momentum in Opzelura and whether Jakafi can hold pricing power as generic threats loom.

    All Incyte Articles

    137 Articles

    1 2 3 10

    Featured Reads

    Our top personal finance-related articles today. Your wallet will thank you later.